BIOMAT Database Logo BIOMAT Database Logo

[Insulin-stimulating properties of Glybenclamide (HB 419) in healthy subjects. Comparative studies with tolbutamide]. 1969

P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D011773 Pyruvates Derivatives of PYRUVIC ACID, including its salts and esters.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014044 Tolbutamide A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Apo-Tolbutamide,Artosin,Diabetol,Diaval,Dolipol,Orabet,Orinase,Rastinon,Tolbutamid R.A.N.

Related Publications

P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
Clinical trial with HB 419 (Glybenclamide).
January 1970, Bulletin of the Calcutta School of Tropical Medicine,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[Experience with HB 419 (glybenclamide) in the ambulatory diabetes treatment].
June 1969, Die Medizinische Welt,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[HB 419 (Glybenclamide) in the treatment of diabetes mellitus].
January 1969, Acta diabetologica latina,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)].
April 1969, Deutsche medizinische Wochenschrift (1946),
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[Blood sugar and plasma insulin levels in children following the oral administration of glybenclamide (HB 419)].
January 1970, Zeitschrift fur Kinderheilkunde,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
A clinical assessment of glybenclamide (HB 419, "Daonil"), a hypoglycaemic sulphonylurea.
August 1969, The Medical journal of Australia,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro].
August 1969, Arzneimittel-Forschung,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[Fertility studies with HB 419].
August 1969, Arzneimittel-Forschung,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[Teratologic studies with HB 419].
August 1969, Arzneimittel-Forschung,
P Brunetti, and G Cozzolino, and F Santeusanio, and D Arena, and P De Ciuceis, and G Marri, and E Migliorini
[Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].
April 1969, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!